GERGEN MARK J (President and CBO) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/2/2024ACC: 0000950170-24-010943
DirectorOfficer· President and CBO
Since Jul 2020
-47.16K
Net shares
Net seller
$160.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
47.16K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−47.16K
Price / share
$3.41
Trade value
$160.82K
% of position
6.4%
2/1/2024
732.61K→685.45K
Total
Net shares
−47.16K
Net value
-$160.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2024 | F · Tax Withholding | −47.16K | $3.41 | $160.82K | 6.4% | 732.61K | 685.45K |
| Total | −47.16K | -$160.82K | ||||||
Derivative Transactions0
No derivative transactions reported